# new treatment for plaque psoriasis approved in europe

Clinical use of dimethyl fumarate in moderate-to-severe plaque-type… » Sep 20, 2018… (1)Psoriasis-Centre at the Department of Dermatology, University Medical Centre… In 2017, the European Medicines Agency (EMA) approved Skilarence® , a new oral… chronic plaque psoriasis in need of systemic therapy. Ncbi.nlm.nih.gov

Guideline on clinical investigation of medicinal products indicated… » Nov 18, 2004… E-mail: [email protected] http://www.emea.eu.int. ©EMEA 2004… PRODUCTS INDICATED FOR THE TREATMENT OF PSORIASIS… studies of new compounds to demonstrate clinical efficacy and safety. It is for… Chronic stable plaque psoriasis (psoriasis vulgaris) is the commonest form of the disease,. Ema.europa.eu

European Commission Approves SKYRIZI™ (risankizumab) for the… » Apr 30, 2019… European Commission Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis… to its p19 subunit, offers moderate to severe psoriasis patients a new therapeutic option… announced that the European Commission (EC) has approved SKYRIZI™ (risankizumab) for ... News.abbvie.com

European approval for Skyrizi, hot on the heels of US - PMLiVE » Apr 30, 2019… The European Commission has approved AbbVie's new… The drug is already in trials for psoriatic arthritis, Crohn's disease and ulcerative ... Pmlive.com

European Commission Approves Risankizumab for Plaque Psoriasis » May 1, 2019… In clinical studies, patients with moderate to severe plaque psoriasis… Use recommended approval of the drug, as reported by Medscape Medical News.… living with moderate to severe psoriasis with a new treatment option ... Medscape.com

New Treatment for Plaque Psoriasis Approved in Europe » Sep 18, 2018… Almirall has received European Commission approval for its plaque psoriasis treatment tildrakizumab (Ilumetri), Sun Pharma announced in a ... Pharmacytimes.com

Kyntheum approved in the EU for the treatment of adults with… » Jul 20, 2017… Kyntheum approved in the EU for the treatment of adults with moderate-to-severe plaque psoriasis… for Kyntheum (brodalumab), a new biologic medicine developed for the treatment of moderate-to-severe plaque psoriasis in ... Astrazeneca.com

STELARA® Receives European Commission Approval For… » Jun 29, 2015… Approval provides new therapeutic option for plaque psoriasis patients aged 12 and older for whom limited approved treatment options are ... Jnj.com

EMA approves Cimzia for use in treating plaque psoriasis | Pharmafile » Jul 2, 2018… The Brussels-based pharmaceutical company UCB has announced that the European Medicines Agency (EMA) has approved a label ... Pharmafile.com

Treating Psoriasis: What Is New About Fumaric Acid Esters… » Jun 7, 2018… Treating Psoriasis: What Is New About Fumaric Acid Esters?….. (EMA) for the treatment of moderate-to-severe plaque psoriasis in adults in ... Emjreviews.com